SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 167 filers reported holding SAGE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,510,000 | -85.2% | 226,679 | -62.8% | 0.07% | -77.5% |
| Q4 2019 | $43,945,000 | +7993.0% | 608,741 | +15613.5% | 0.32% | +8025.0% |
| Q3 2019 | $543,000 | -98.9% | 3,874 | -98.5% | 0.00% | -98.9% |
| Q2 2019 | $47,736,000 | +15.9% | 260,725 | +0.7% | 0.36% | +22.9% |
| Q1 2019 | $41,174,000 | +957.6% | 258,877 | +372.6% | 0.29% | +910.3% |
| Q1 2017 | $3,893,000 | -3.0% | 54,781 | -30.3% | 0.03% | -6.5% |
| Q4 2016 | $4,015,000 | -61.9% | 78,641 | -65.7% | 0.03% | -63.1% |
| Q3 2016 | $10,543,000 | – | 228,954 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |